Penn Medicine Launched Proton Therapy Clinical Trial
The new study tests a ultra-fast radiation technique in Philadelphia for patients with recurrent head and neck cancer.
Updated on Oct. 1, 2026 in Cancer
Live Poll
Would you prefer a faster, high-intensity radiation treatment even if it is still experimental?
Penn Medicine has initiated a Phase I clinical trial at the Roberts Proton Therapy Center to evaluate ConformalFLASH proton therapy. The study aims to refine radiation delivery for 10 patients with recurrent head and neck cancer who are currently ineligible for surgery.
Why it matters
Patients with recurring head and neck cancers often face grueling side effects from conventional radiation, which can require 25 to 35 treatment sessions. This research seeks to reduce both the total time spent in medical facilities and the severity of side effects for this high-need population.
This Phase I clinical trial involves 10 patients receiving a five-treatment protocol over 10 days at the Roberts Proton Therapy Center. While Penn Medicine previously completed a study in pet dogs, this remains a preliminary investigation into the technique's application in humans.
The players
Penn Medicine
An academic medical center that conducts advanced research and specializes in oncology and proton therapy.
Ion Beam Applications
A developer of particle accelerator technology that manufactures medical equipment for proton therapy.
Roberts Proton Therapy Center
A clinical facility in Philadelphia dedicated to delivering precision radiation treatments for cancer patients.
The details
ConformalFLASH proton therapy combines high-speed radiation delivery—where doses are administered in less than one second—with 3D mapping technology. By using imaging exams to define precise tumor boundaries, the system aims to focus radiation strictly on the cancer while sparing surrounding healthy tissue. This approach is intended to provide a more efficient alternative to standard radiotherapy.
Timeline
The clinical trial launched in October 2026.
The facility expects to open its fourth proton therapy center in late 2027.
Health Landscape
This study builds upon the long-standing use of proton therapy as a specialized tool for targeting tumors in sensitive areas. It represents a pivot toward shorter, higher-intensity treatment schedules that aim to surpass the limitations of conventional radiation cycles.
This trial is specifically for patients with recurrent head and neck cancer who cannot undergo surgery. Interested individuals should discuss with their oncologist whether clinical trials are appropriate for their specific case or contact the study coordinator at 267-250-9244.
The takeaway
This trial explores a potential reduction in the intensity and duration of radiation care for those with recurring head and neck cancer. If you are managing a complex cancer diagnosis, consult your physician about whether clinical trials at local centers could provide access to emerging treatment methods.
Further reading
For more on evolving treatment options, visit the Cancer section.
Source note: This article includes information reported by OncLive.
Live Poll
Would you prefer a faster, high-intensity radiation treatment even if it is still experimental?
